DV
Dividend Vision

VNDA — Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. (VNDA)

Total return is -46.1% over the past 20.3 years, 819.9 points behind SPY at 773.8%. Its deepest 1-year drawdown was 48.4%.

VNDA is a single-stock equity holding in Vanda Pharmaceuticals Inc., a pharmaceutical company, rather than a diversified ETF. The security does not currently pay distributions, making it unsuitable for income-focused investors seeking regular dividend payments. This holding may appeal to investors seeking exposure to the pharmaceutical sector, though it carries the concentration risk of a single company position rather than the diversification typical of traditional ETFs.

VNDA key facts

Asset type
Stock
Asset class
Equity
Inception date
04/12/2006
Distribution frequency
None
Last close
$5.22
Market cap
$315,615,232
Average volume
964700.0
Beta
0.638
Payout ratio
0.0
Forward P/E
103.0928
EPS
$-4.82